Procter & Gamble Health Ltd

NSE: PGHL · BSE: 500126 · Pharmaceuticals & Biotechnology · 22 announcements

Share price: ₹5,234.00
Market cap: ₹8,688 Cr
Revenue (annual): ₹1,408 Cr
Net profit (annual): ₹326.9 Cr
P/E (TTM): 24.3×Sector 47.3×
Promoter holding: 51.82%+0.00% QoQ
FII holding: 6.33%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 3 Financial Results 3 Dividend 3 Annual General Meeting 3 Results Update 2 Other Announcement 2 Merger & Restructuring 1 Business Update 1 Board Meeting Outcome 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

6 Aug 2026 13:59 IST NSE

Financial Results

Procter & Gamble Health Q1 FY27 Results: Net Profit ₹96.2 Cr, Up 45.3% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹363.7 Cr (+7.4% YoY) and net profit of ₹96.2 Cr (+45.3% YoY) for Q1 FY27.

Key figure: Net profit ₹96.2 Cr · +45.3% YoY

Open full results → Read the filing ↗

26 May 2026 16:55 IST BSE

Financial ResultsAlfa Alert

Procter & Gamble Health Q4 FY26 Results: Net Profit ₹94.6 Cr, Up 54.6% YoY

Procter & Gamble Health Ltd reported revenue from operations of ₹370.4 Cr (+19.1% YoY) and net profit of ₹94.6 Cr (+54.6% YoY) for Q4 FY26.

Key figure: Net profit ₹94.6 Cr · +54.6% YoY

Open full results → Read the filing ↗

26 May 2026 16:54 IST BSE

Financial Results

Procter & Gamble Health Financial Results

Procter & Gamble Health reported a ₹449.86 Crore profit before tax for FY2026. The board recommended a ₹45 per share dividend, reflecting strong annual performance.

Value: ₹449.9 Cr

Read the filing ↗